Drug Discovery & Translational Medicine Symposium
UCL Guest Speaker - Quentin Pankhurst
Quentin Pankhurst is the Director of the Institute of Biomedical Engineering at University College London. The objective of the IBME is to bring together UCL’s excellence in academic and clinical R&D – around a thousand staff, fellows, nurses and students in 35 different centers, departments and institutes – to create a world leading research center for biomedical engineering. The IBME’s goal is to be the world’s fastest and most cost-effective deliverer of patient benefit by harnessing the power of university-based innovation and experimental medicine in the UK.
He is also the Director of the Davy-Faraday Research Laboratory and Wolfson Professor of Natural Philosophy – a post once held by Lord Ernest Rutherford – at the Royal Institution of Great Britain, in London. Here he runs research programs in bio- and nanomagnetism aimed at making practical advances in the use of magnetic nanoparticles in healthcare. These include medical imaging devices, targeted regenerative medicine, molecular imaging microscopy for living cells, and the development of multi-functional nanoparticles for therapy and diagnostics.
Dr. Pankhurst is a founder and CTO of Endomagnetics Ltd, a spin-out company which is commercializing the SentiMag™, an intra-operative device for breast cancer surgery.